Day: June 18, 2024

Barfresh Strengthens Executive Team with New Industry Leading Vice President of Sales

Written by Customer Service on . Posted in Public Companies.

Tony Grossi Brings Over 25 Years of Vice President and Director-Level Experience in Beverage and Food Service Sales Strategic Leadership Hire Follows Recent Addition of Vice President of Supply Chain & Co-Manufacturing, Fortifying Executive Team for Significant Sales Uplift Expected in Fiscal Year 2024 and Beyond LOS ANGELES, June 18, 2024 (GLOBE NEWSWIRE) — Barfresh Food Group Inc. (the “Company” or “Barfresh”) (Nasdaq: BRFH), a provider of frozen, ready-to-blend and ready-to-drink beverages, today announced the appointment of Tony Grossi as Vice President of Sales. In this role, Tony will leverage his successful experience by spearheading Barfresh’s sales efforts, overseeing all sales efforts including the Companies expanding sales network. Tony Grossi comes to Barfresh with over 25 years of vice president and director-level...

Continue reading

Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC) Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers

Written by Customer Service on . Posted in Public Companies.

Day One receives exclusive license for development and commercialization of MTX-13 (DAY301), which received IND clearance by the FDA in April 2024 Targets PTK7, highly expressed in broad range of adult and pediatric solid tumors BRISBANE, Calif., June 18, 2024 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a commercial-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced it has entered into an exclusive licensing agreement (the Agreement) with MabCare Therapeutics (MabCare) for MTX-13, a novel ADC targeting protein-tyrosine kinase 7 (PTK7). Pursuant to the terms of the Agreement, Day One has exclusive rights to develop, manufacture, and commercialize MTX-13 worldwide, excluding...

Continue reading

Elicio Therapeutics Reports Inducement Grants

Written by Customer Service on . Posted in Public Companies.

BOSTON, June 18, 2024 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that on June 17, 2024, the Company granted an aggregate of 5,400 inducement stock options to two new employees, as an inducement material to each individual entering into employment with Elicio in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement stock options were approved by the Compensation Committee of Elicio’s Board of Directors and granted under the Elicio Therapeutics, Inc. 2024 Inducement Incentive Award Plan. Each grant provides for the purchase of shares of Elicio common stock at a price of $7.98 per share, the closing price per share of Elicio common stock as...

Continue reading

Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology

Written by Customer Service on . Posted in Public Companies.

Pharmacokinetic study is key step on path to expansion into US market NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it is entering the next phase of its planned 510(k) submission to the FDA. The Company has successfully completed subject screening for its Pharmacokinetic (PK) Study and will begin dosing and sampling study subjects today. INBS’ PK study is a key step towards the Company’s planned 510(k) submission to the FDA during the fourth quarter of this year. FDA clearance is required to show that INBS’ fingerprint drug screening technology is safe and effective and would result in the Company’s ability to enter the substantial...

Continue reading

Chijet Motor Initiates Business of Automobile Culture Tourism

Written by Customer Service on . Posted in Public Companies.

JILIN CITY, China, June 18, 2024 (GLOBE NEWSWIRE) — Chijet Motor Company, Inc. (Nasdaq: CJET) (the “Company” or “Chijet”), a high-tech enterprise engaged in the development, manufacture, sales, and service of traditional fuel vehicles and new energy vehicles (“NEV”) in China announced that on June 7, The holding subsidiary FAW Jilin Automobile Co., Ltd. (“FAW JiLin”) of Chijet Motor signed an intention agreement with the administration committee of Jilin National High-tech Industrial Development Zone and Haikou BIAOCHI Automobile Culture Development Co., Ltd. (“BIAOCHI”) for automobile industry culture tourism and race automobile R&D and manufacture. FAW JiLin and BIAOCHI will cooperate to do project of automobile culture tourism with northeast ice-snow tourism characteristics. Depending on the automobile R&D and manufacture...

Continue reading

NANO Nuclear Energy Senior Director and Head of Reactor Design Prof. Massimiliano Fratoni Honored at American Nuclear Society’s Annual Conference 2024 and Awarded the Untermyer & Cisler Reactor Technology Metals

Written by Customer Service on . Posted in Public Companies.

Figure 1 Jay Jiang Yu, Executive Chairman and President of NANO Nuclear Energy Inc. alongside Professor Massimiliano Fratoni, Ph.D., Senior Director and Head of Reactor Design, who was awarded the Untermyer & Cisler Reactor Technology Metals at the 2024 Annual Conference Hosted by the American Nuclear Society. Chair of University of California Berkeley Nuclear Engineering Department, NANO Nuclear Energy Head of Reactor Design and ‘ZEUS’ Development Lead, Prof. Massimiliano Fratoni recognized for his excellence in advanced reactor development. New York, N.Y., June 18, 2024 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear”), an emerging vertically integrated microreactor and advanced nuclear technology company led by a world-class nuclear engineering team developing proprietary, portable, and...

Continue reading

BIGG Digital Assets Subsidiary TerraZero Deploys Stripe Integration for Intraverse Ecommerce to Generate Revenue

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of Netcoins, Blockchain Intelligence Group, and TerraZero is pleased to report that TerraZero has successfully implemented Stripe into their Intraverse technology ecosystem to facilitate ecommerce for merchants, artists, brands, and TerraZero. TerraZero worked with PricewaterhouseCoopers to form a go-to-market strategy for payments, culminating in the selection of Stripe as the technology for payments. This gives artists, brands, creators and other merchants looking to monetize their crafts on Intraverse a secure way to sell, and an equally secure system for users across the platform to make purchases. Stripe saw an increase...

Continue reading

Prenetics Announces First Quarter 2024 Financial Results

Written by Customer Service on . Posted in Public Companies.

First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter Confirms Strategic Pivot Targeting the U.S. Consumer Healthcare Market Reaffirms 2024 Revenue Range of US$33 million to US$36 million LOS ANGELES, June 18, 2024 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced unaudited financial results for the first quarter ended March 31, 2024, along with recent business updates. First Quarter 2024 Financial Highlights Revenue from continuing operations of US$6.4 million in the first quarter 2024, an increase of 30.2% as compared to the first quarter 2023. Gross profit from continuing operations of US$3.8 million in the first quarter 2024, an increase of 159.8% as compared to the first quarter 2023. Adjusted...

Continue reading

FOXO Technologies Inc. Secures Up to $2.8 Million in Senior Notes to Fund Previously Announced Acquisition of Myrtle Recovery Centers, Inc. and Provide Additional Working Capital

Written by Customer Service on . Posted in Public Companies.

MINNEAPOLIS, MN, June 18, 2024 (GLOBE NEWSWIRE) — FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), today announced that it has secured up to $2.8 million in Senior Notes from an institutional investor (“Investor”) to fund the previously announced acquisition of Myrtle Recovery Centers, Inc. as well as provide additional working capital to support the Company’s growth strategy.  Mark White, Interim CEO of FOXO, said, “We appreciate the support of this institutional investor, which we believe is further validation of our business model. Specifically, we intend to use the proceeds to complete the acquisition of Myrtle Recovery Centers, Inc., as well as advance our planned acquisition of Scott County Community Hospital, Inc. (d/b/a Big South Fork Medical Center). As previously noted, we believe these two acquisitions...

Continue reading

La Rosa Holdings Corp Announces Plans to Acquire Controlling Interest in Red Door Title

Written by Customer Service on . Posted in Public Companies.

Title insurance capabilities aimed at broadening service offerings and equipping agents with new tools to compete and win in the market Celebration, FL, June 18, 2024 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a holding company for five agent-centric, technology-integrated, cloud-based, multi-service real estate segments, today announced that it has entered into a non-binding Letter of Intent to acquire a controlling interest in Nona Title Agency, which operates under the name Red Door Title, a full-service escrow settlement and title company headquartered in Orlando, Florida. The Company anticipates finalizing the transaction by the end of July. Once complete, the transaction would allow La Rosa to provide title insurance services for home purchases and sales, complementing its existing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.